All In Biotech

Drug Trial Radar · NCT00333372

To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia

To Evaluate the Efficacy of Z-338 in Subjects With Functional Dyspepsia, Focusing on the Assessment of Subjective Symptoms

Last checked: Nov 19, 2026Latest source record: Jan 14, 2009 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 440 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

440

Actual

Start

Apr 2006

Primary completion

Not stated

Sponsor

Lead sponsor
Zeria PharmaceuticalIndustry
Sponsor type
Industry
First posted
Jun 5, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 20 years, up to 79 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To Evaluate the efficacy of Z-338 in subjects with Functional Dyspepsia, focusing on the assessment of subjective symptoms in order to further determine the optimal dosage and efficacy parameters for PhaseIII clinical trials.

Conditions

  • Functional Dyspepsia

Interventions

  • Z-338Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. General impression at last visit

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Tohoku University

    Sendai, Japan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.